|
|
 Dr. Forbes' many years of academic and industry experience allow Aclairo® to offer the same level of expertise in phototoxicology that we offer in other areas of preclinical consulting. Previously, Dr. Forbes was a Professor of Dermatology at Temple University, built and managed Argus' Center for Photobiology for more than a decade, and also consulted on an independent basis in the area of photobiology for about 20 years. In 1998, as acknowledgement of his experience and contributions to the field of toxicology, Dr. Forbes was admitted as a Fellow to the Academy of Toxicological Sciences.
Dr. Forbes has extensive experience with topical dermal and systemic pharmaceuticals, including psoralens, fluoroquinolones, porphyrins, photodynamic therapy drugs, sunscreens, immunosuppressive compounds, melanogenic products, retinoids, peroxides, Vitamin D derivatives, sunscreen formulations and corticosteroids, along with numerous photobiologically important devices. He continues to be one of the central figures in expanding the pharmaceutical industry's understanding of photobiology through his pioneering work on animal models and his over 100 published papers. Furthermore, he has advanced the development of comparative (clinical and preclinical) phototoxicity testing; developed standardized protocols for photocarcinogenesis testing; and helped establish the standard for light sources for photocarcinogenesis testing in laboratory animals.
Dr. Forbes has served on various expert committees, including those responsible for the Psoralen-UVA (PUVA) consensus document; the IARC monograph on UVR; and prevention of cancer with sunscreens. These documents provide the basis for the latest thinking on the scientific and public health issues associated with exposure to sunlight. |
|
|
